These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17434711)

  • 1. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
    Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
    Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).
    Veltri A; Moretto P; Doriguzzi A; Pagano E; Carrara G; Gandini G
    Eur Radiol; 2006 Mar; 16(3):661-9. PubMed ID: 16228211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiofrequency ablation for hepatocellular carcinoma].
    Inagaki M; Yagi T; Sadamori H; Matsuda H; Matsukawa H; Ishikawa T; Tanaka N; Mimura H; Yasui K; Kanazawa S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2242-5. PubMed ID: 12484046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session.
    Bonomo G; Della Vigna P; Monfardini L; Orgera G; Chiappa A; Bianchi PP; Zampino MG; Orsi F
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1372-9. PubMed ID: 22271077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
    Chung IK; Park MJ; Kwon KT; Park YD; Chung YJ; Jeon SW; Lee MK; Seo HE; Lee YD; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
    Korean J Hepatol; 2005 Dec; 11(4):371-80. PubMed ID: 16380666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
    Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.